1. Citigroup currently has a “buy” rating on Leidos stock.
2. Leidos stock has a 52-week low of $31.76 and a 52-week high of $47.18.
3. The stock has a 50-day moving average of $41, according to the report. The stock’s 200-day moving average is $42.
4. Leidos has a market cap of $3.03 billion.
5. Jefferies Group set the company’s price target at $42. Credit Suisse set the price target at $41.
More articles on finance issues:
The finance function of tomorrow: 5 takeaways
Payment disruption in healthcare: Which factors will have a high impact?
How health systems can take control of purchased services
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit
